학술논문
Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03
Document Type
Article
Author
Garcia-Donas, J.; Prieto, M.; Rodriguez-Moreno, J.F.; Navarro, P.; Hurtado, A.; Garrigos, L.; Taus, A.; Santaballa, A.; Redondo, A.; Vidal, L.; Lainez, N.; Guerra, E.; Rodriguez, V.; Cueva, J.; Bover, I.; Palacio, I.; Rubio, M.J.; Lopez-Guerrero, J.A.; Garcia-Casado, Z.; Garcia-Martinez, E.; de Castro, I.P.; Grande, E.
Source
In: Clinical and Translational Oncology . (Clinical and Translational Oncology, July 2023, 25(7):2090-2098)
Subject
Language
English
ISSN
16993055
1699048X
1699048X